Literature DB >> 8055200

The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register.

D P Symmons1, E M Barrett, C R Bankhead, D G Scott, A J Silman.   

Abstract

This paper provides the first data on the incidence of RA based on a prospective population-based register. All new cases of inflammatory polyarthritis in the Norwich Health Authority are notified by general practitioners to the Norfolk Arthritis Register. The patients are then clinically evaluated by metrologists and blood taken for RF estimation. Cases of RA were defined as all those notified with an onset of symptoms in 1990; who presented by 31 December 1991; and who satisfied the 1987 ARA criteria for RA at the time of presentation. Two hundred and ten patients were notified in the defined time-frame, of whom 104 were classified as having RA. The annual incidence rate was 36/100,000 for women and 14/100,000 for men. RA was rare in men aged under 45 yr. The incidence in men rose steeply with age. The incidence in women rose up to age 45 yr, plateaued to age 75 yr, and fell in the very elderly.

Entities:  

Mesh:

Year:  1994        PMID: 8055200     DOI: 10.1093/rheumatology/33.8.735

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  115 in total

1.  Contraceptives, pregnancy, and RA.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

2.  Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis: a nationwide cohort study.

Authors:  Ane L Rom; Chun S Wu; Jørn Olsen; Hanne Kjaergaard; Damini Jawaheer; Merete L Hetland; Mogens Vestergaard; Lina S Mørch
Journal:  Arthritis Rheumatol       Date:  2014-12       Impact factor: 10.995

3.  Parental rheumatoid arthritis and long-term child morbidity: a nationwide cohort study.

Authors:  Ane Lilleøre Rom; Chun Sen Wu; Jørn Olsen; Damini Jawaheer; Merete Lund Hetland; Bent Ottesen; Lina Steinrud Mørch
Journal:  Ann Rheum Dis       Date:  2015-12-23       Impact factor: 19.103

4.  Incidence of rheumatoid arthritis from 1995 to 2001: impact of ascertainment from multiple sources.

Authors:  Jens K Pedersen; Niels K Kjaer; Anders J Svendsen; Kim Hørslev-Petersen
Journal:  Rheumatol Int       Date:  2008-10-14       Impact factor: 2.631

Review 5.  Sarilumab for Previously-Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors:  Iñigo Bermejo; Shijie Ren; Emma Simpson; Mark Clowes; David L Scott; Adam Young; Matt Stevenson
Journal:  Pharmacoeconomics       Date:  2018-12       Impact factor: 4.981

Review 6.  Should patients with recent onset rheumatoid arthritis be offered genetic screening?

Authors:  D P Symmons; W E Ollier; P Brennan; A J Silman
Journal:  Ann Rheum Dis       Date:  1996-07       Impact factor: 19.103

Review 7.  Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors:  Lesley Uttley; Iñigo Bermejo; Shijie Ren; Marrissa Martyn-St James; Ruth Wong; David L Scott; Adam Young; Matt Stevenson
Journal:  Pharmacoeconomics       Date:  2018-09       Impact factor: 4.981

8.  Prevalence and incidence of rheumatoid arthritis in South Korea.

Authors:  Yoon-Kyoung Sung; Soo-Kyung Cho; Chan-Bum Choi; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2012-12-20       Impact factor: 2.631

9.  The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis.

Authors:  M J Harrison; L M Davies; N J Bansback; M J McCoy; S M M Verstappen; K Watson; D P M Symmons
Journal:  Qual Life Res       Date:  2009-09-24       Impact factor: 4.147

10.  Annual incidence of inflammatory joint diseases in a population based study in southern Sweden.

Authors:  M K Söderlin; O Börjesson; H Kautiainen; T Skogh; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.